BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 423309)

  • 21. Liver tumor promoters and other mouse liver carcinogens.
    Ward JM; Diwan BA; Lubet RA; Henneman JR; Devor DE
    Prog Clin Biol Res; 1990; 331():85-108. PubMed ID: 2179967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in vivo rodent test systems for assessment of carcinogenic potential.
    van der Laan JW; Spindler P
    Regul Toxicol Pharmacol; 2002 Feb; 35(1):122-5. PubMed ID: 11846641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some genetic considerations for the design of better mammalian assay systems for the detection of chemical mutagens and carcinogens.
    Wolff GL
    J Environ Pathol Toxicol; 1977; 1(2):79-90. PubMed ID: 553144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of the guppy, Poecilia reticulata, in carcinogenicity testing: special advantages and problems.
    Zimmerer EJ
    Natl Cancer Inst Monogr; 1984 May; 65():59-64. PubMed ID: 6462199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of pharmacogenetics on toxicological studies. Statistical implications.
    Lovell DP
    J Exp Anim Sci; 1993 Sep; 35(5-6):259-81. PubMed ID: 8218441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemicals classified by IARC: their potency in tests for carcinogenicity in rodents and their genotoxicity and acute toxicity.
    McGregor DB
    IARC Sci Publ; 1992; (116):323-52. PubMed ID: 1428089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Techniques for carcinogenicity studies.
    Weisburger EK
    Cancer Res; 1981 Sep; 41(9 Pt 2):3690-4. PubMed ID: 7260925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strain A mouse pulmonary tumor test results for chemicals previously tested in the National Cancer Institute carcinogenicity tests.
    Maronpot RR; Shimkin MB; Witschi HP; Smith LH; Cline JM
    J Natl Cancer Inst; 1986 Jun; 76(6):1101-12. PubMed ID: 3458947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiamethoxam induced mouse liver tumors and their relevance to humans. Part 2: species differences in response.
    Green T; Toghill A; Lee R; Waechter F; Weber E; Peffer R; Noakes J; Robinson M
    Toxicol Sci; 2005 Jul; 86(1):48-55. PubMed ID: 15716476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NTP Comparative Initiation/Promotion Skin Paint Studies of B6C3F1 Mice, Swiss (CD-1(R)) Mice, and SENCAR Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Feb; 441():1-201. PubMed ID: 12595922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans.
    McGlynn KA; Hunter K; LeVoyer T; Roush J; Wise P; Michielli RA; Shen FM; Evans AA; London WT; Buetow KH
    Cancer Res; 2003 Aug; 63(15):4594-601. PubMed ID: 12907637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impacts of chemicals on liver cancer risk.
    Wogan GN
    Semin Cancer Biol; 2000 Jun; 10(3):201-10. PubMed ID: 10936069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current problems in the choice of animals for toxicity testing.
    Stevenson DE
    J Toxicol Environ Health; 1979 Jan; 5(1):9-15. PubMed ID: 423310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.